A pretreatment MRI in men undergoing radical prostatectomy can provide independent prognostic value for oncologic outcomes, a systematic review and meta-analysis indicated. MRI-detected extraprostatic ...

Genomic risk classifier performance in PET-guided post-prostatectomy patients: Secondary analysis of a randomized trial.

Prostate cancer surgeons routinely use MRI to guide surgical planning, yet imaging findings are not used for risk stratification in standard prognostic models. A new meta-analysis suggests they should ...

Clinical outcomes of patients with grade group 1 prostate cancer with extraprostatic extension: Results from up to 25 years of follow-up.

Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...